Taiwan FDA registration 583d89082f303f56210a07ceea3ada60

Innova MPO immunoglobulin G enzyme linked immunoassay panel

TW: 因諾瓦MPO免疫球蛋白G酵素連結免疫分析法試劑組

Taiwan·Risk Class 2·INOVA DIANOSTICS, INC.·Registered Apr 21, 2006 – Apr 21, 2026Expired

Registration details

Analysis ID: 583d89082f303f56210a07ceea3ada60
Customs Code: DHA00601645001

Company information

Manufacturer: INOVA DIANOSTICS, INC.
Manufacturer Country: United States
Authorized Representative: TRUGENE DIAGNOSTICS, INC.

Product details

Intended Use: Semi-quantitative detection of myeloperoxidase (MPO) antibody immunoglobulin G (IgG) in human serum samples was performed by Enzyme-Linked Immunoassay.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.5560 乳酸去氫酵素免疫試驗系統
Import Information: import

Dates and status

Registration Date: Apr 21, 2006
Expiry Date: Apr 21, 2026

About this record

Access comprehensive regulatory information for Innova MPO immunoglobulin G enzyme linked immunoassay panel in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 583d89082f303f56210a07ceea3ada60 and manufactured by INOVA DIANOSTICS, INC.. The authorized representative in Taiwan is TRUGENE DIAGNOSTICS, INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.